The Councillor for Economic Promotion, Pedro Martínez, took part today in the opening of the Iberobio Project Funding Forum, held at the Salamanca City Council’s Biotechnology Business Incubator (Abioinnova), where he highlighted the potential of Salamanca’s biotechnology ecosystem.
During the event, Pedro Martínez emphasized the importance of funding and investors for the development of the projects hosted at Abioinnova, as well as the potential of the Iberobio project as a driver of the cross-border Iberian ecosystem.
The Iberian Biotech Funding Forum Castilla y León brought together a broad panel of financial entities, investment funds and strategic institutions in the biotechnology sector. Among the financial agents and investors attending were the Mind The Gap Fund of Fundación Botín, Netaccede, Sabadell Gallego, Ibercaja, Iberaval, ICECYL, as well as investor and consultant Álvaro Espejo and representatives from UTSAL–ETSII Béjar.
The session included a pitch round in which six innovative projects based at Abioinnova presented their proposals to investors. RareBioTech opened the presentations with its high-capacity lentiviral technology that enables the study of large genes, a key tool for advancing advanced therapies and precision medicine.
Next, Labregando showcased its solution for transforming livestock slurry management into RENURE biofertilizers. For its part, Virofend presented its avian oncolytic virus for immunotherapy in metastatic colorectal cancer, while MycoThink demonstrated its fungi-based technology for accelerating waste degradation in landfills.
The pitch round concluded with the presentation by HARMONY Alliance Foundation, dedicated to the ethical and secure exploitation of health data in haematology using Big Data, and Gstard, which is launching an AI platform to evaluate and classify patents for investment purposes.
This Forum marks the culmination of the workshops delivered to Abioinnova companies and ecosystem members, providing guidance in the areas of internationalization and financing.